SITC 2023: RNA Post-Conference Report

Our Beacon RNA experts have screened each abstract from the 2023 SITC Annual Meeting, held on 1st to the 5th November, to identify 50 RNA-relevant abstracts (11 clinical, 2 trial outlines and 37 preclinical). These have been listed and summarised in order of presentation in our Post-Conference Report.

SITC 2023: RNA Abstract Highlights

This report sample provides a complete guide to all RNA-relevant abstracts presented at the 2023 SITC conference, offering you a concise summary of each abstract as well as some additional analysis.

You May Also Be Interested In…

Learn More About RNA

What is Beacon RNA?
  • The Most Comprehensive Way to Search the RNA Drug Development Landscape: Unique search ontologies based on RNA drug and trial characteristics
  • Market Leading Approach to RNA Preclinical & Clinical Data Curation: Manual curation of key RNA research and development data points by RNA research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search RNA company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon RNA Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search